Market research
2385.TSE Soiken Holdings Inc
TSE JPY Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 6B
- P/E ratio
- 26.76
- Analyst target
- 600
- Dividend yield
- 4.6%
- Beta
- 0.13
Profile
Instrument facts
- Exchange
- TSE
- Currency
- JPY
- Sector
- Healthcare
- Industry
- Biotechnology
- ISIN
- JP3431850001
- Market cap
- 6B
- P/E ratio
- 26.76
- Analyst target
- 600
- Dividend yield
- 4.6%
- Beta
- 0.13
About
About Soiken Holdings Inc
Soiken Holdings Inc. engages in the development of biomarkers in Japan and internationally. The company is involved in the development and sale of cosmetics and dietary supplements comprising imidapeptides; licensing and development of biomarker technology; provision of marketing research and post-marketing surveys for dietary supplements; and research, development, and sale of functional materials, such as lactoferrin, as well as pharmaceutical products from ascochlorin derivatives. It also provides clinical evaluation tests for foodstuffs using biomarker technology; support for pharmaceutical clinical research and epidemiology studies; and services to health insurance societies, including contracted health guidance, specific health checkup promotion services for the dependents of insured, and service to prevent diabetes. Soiken Holdings Inc. was incorporated in 1994 and is headquartered in Toyonaka, Japan.
Research context
Soiken Holdings Inc appears in PyInvesting’s Tokyo Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- JPY
- Sector
- Healthcare
- Industry
- Biotechnology
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the 2385.TSE discussion.
5 years, 6 months ago
Soiken Holdings Inc is currently in a long term downtrend where the price is trading 31.0% below its 200 day moving average.
From a valuation standpoint, the stock is 98.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.4.
Soiken Holdings Inc's total revenue rose by 17.0% to $3B since the same quarter in the previous year.
Its net income has dropped by 5.0% to $346M since the same quarter in the previous year.
Based on the above factors, Soiken Holdings Inc gets an overall score of 2/5.